MedRisk and CWCS sign partnership agreement

MedRisk, Inc. has entered into an agreement with Coventry Workers' Comp Services (CWCS), a division of Coventry Health Care, Inc.

MedRisk, a claims services and specialty managed care company serving the workers’ compensation industry, will provide physical medicine management services to CWCS clients using the Coventry Integrated NetworkSM.

Under this new program, injured workers will have access to MedRisk’s national network of physical therapists, occupational therapists and chiropractors who specialize in the treatment of work-related injuries. CWCS clients will benefit from MedRisk’s prospective and retrospective physical medicine management services that deliver superior network savings.

“A recent NCCI study shows workers’ comp claims severity is increasing at 3 ½ times the rate of medical inflation,” says MedRisk CEO Shelley Boyce. “More than 20 percent of comp claims involve physical medicine, making it a significant driver of these rising costs. Through our unique evidence-based medical management program, CWCS clients will enjoy lower physical medicine costs and better medical outcomes.”

CWCS plans to introduce MedRisk’s innovative network solution to existing clients in the upcoming months as part of CWCS’ new physical medicine program. The program will also be included in its national medical network offering for all new clients.

Posted in:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
EAGLE model predicts key lung cancer mutations from routine biopsy